Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Figure from Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers
Home
Publications
Supplementary Figure from Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers
Supplementary Figure from Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers
Authors:
MH
Maija Hollmén
Maija Hollmén
MM
Mikael Maksimow
Mikael Maksimow
JR
Jenna H. Rannikko
Jenna H. Rannikko
MK
Matti K. Karvonen
Matti K. Karvonen
MV
Marita Vainio
Marita Vainio
SJ
Sirpa Jalkanen
Sirpa Jalkanen
MJ
Markku Jalkanen
Markku Jalkanen
JM
Jami Mandelin
Jami Mandelin
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
3 April 2023
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/1535-7163.22522876
Abstract
Supplementary Figure from Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers
Keywords
ANTIBODY
NONCLINICAL CHARACTERIZATION
FIGURE FROM NONCLINICAL
CHARACTERIZATION OF BEXMARILIMAB
SUPPLEMENTARY FIGURE
CLEVER
Related articles
Scroll to top